| LP183707-1 | Non-treponemal or treponemal test was performed at first prenatal visit | COMPONENT | 1 |
| LP183708-9 | Non-treponemal or treponemal test was performed at 28-32 weeks gestation | COMPONENT | 1 |
| LP183709-7 | Date of most recent non-treponemal test | COMPONENT | 1 |
| LP18371-2 | Monoacetyldapsone | COMPONENT | 1 |
| LP183710-5 | Most recent non-treponemal test titer | COMPONENT | 1 |
| LP183712-1 | First non-treponemal test result | COMPONENT | 1 |
| LP183713-9 | First non-treponemal test titer | COMPONENT | 1 |
| LP183715-4 | Date of first treponemal test | COMPONENT | 1 |
| LP183716-2 | First treponemal test type | COMPONENT | 1 |
| LP183717-0 | First treponemal test result | COMPONENT | 1 |
| LP183718-8 | Date of most recent treponemal test | COMPONENT | 1 |
| LP183719-6 | Most recent treponemal test type | COMPONENT | 1 |
| LP18372-0 | 18-Hydroxydeoxycortisol | COMPONENT | |
| LP183720-4 | Most recent treponemal result | COMPONENT | 1 |
| LP183721-2 | HIV status during pregnancy | COMPONENT | 1 |
| LP183722-0 | Clinical stage of syphilis during pregnancy | COMPONENT | 1 |
| LP183723-8 | Surveillance stage of syphilis during pregnancy | COMPONENT | 1 |
| LP183724-6 | Date of first syphilis treatment during pregnancy | COMPONENT | 1 |
| LP183726-1 | Date of first reactive non-treponemal test | COMPONENT | 1 |
| LP183727-9 | First reactive non-treponemal test titer | COMPONENT | 1 |
| LP183728-7 | Non-treponemal test was reactive | COMPONENT | 1 |
| LP183729-5 | Date of first reactive treponemal test | COMPONENT | 1 |
| LP183730-3 | Darkfield exam, DFA, or special stain was performed and test findings | COMPONENT | 1 |
| LP183731-1 | Clinical signs of congenital syphilis | COMPONENT | 1 |
| LP183732-9 | Long bone x-rays were performed and consistent with congenital syphilis | COMPONENT | 1 |
| LP183733-7 | CSF Venereal Disease Research Laboratory test was performed and test findings | COMPONENT | 1 |
| LP183735-2 | Leukocyte count or protein test was performed on CSF and test findings | COMPONENT | 1 |
| LP183736-0 | Syphilis treatment was given and treatment description | COMPONENT | 1 |
| LP183737-8 | Congenital syphilis case classification status | COMPONENT | 1 |
| LP183738-6 | Stillbirth indicator | COMPONENT | 1 |
| LP183739-4 | Mother had appropriate serologic response following syphilis treatment | COMPONENT | 1 |
| LP183740-2 | Birth weight indicator | COMPONENT | 1 |
| LP183741-0 | Gestational age indicator | COMPONENT | 1 |
| LP183742-8 | Fatty acids pattern | COMPONENT | 3 |
| LP183744-4 | Congenital syphilis case investigation and report panel | COMPONENT | 1 |
| LP183745-1 | Maternal information section | COMPONENT | 1 |
| LP183746-9 | Infant or child information section | COMPONENT | 1 |
| LP183747-7 | Congenital syphilis case classification section | COMPONENT | 1 |
| LP183748-5 | Non-treponemal or treponemal test was performed at delivery | COMPONENT | 1 |
| LP18375-3 | Levoamphetamine | COMPONENT | |
| LP183750-1 | Most recent non-treponemal test result | COMPONENT | 1 |
| LP183751-9 | Date first non-treponemal test | COMPONENT | 1 |
| LP183752-7 | When mother received first dose of benzathine penicillin | COMPONENT | 1 |
| LP183753-5 | Amount of benzathine penicillin treatment | COMPONENT | 1 |
| LP183754-3 | Treponemal test was reactive | COMPONENT | 1 |
| LP183756-8 | Aspergillus restrictus | COMPONENT | |
| LP183757-6 | Dimethylacetals (DMA) | COMPONENT | |
| LP183758-4 | Gram negative bacteria | COMPONENT | |
| LP183759-2 | Gram negative bacteria identified | COMPONENT | 2 |
| LP183760-0 | Sterols | COMPONENT | |